Drug Trial Radar · NCT06226571
A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
Last checked: Nov 19, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
96
Actual
Start
May 21, 2024
Primary completion
Feb 2027
Study completion Feb 2027
Sponsor
- Lead sponsor
- Syndax PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jan 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and clinical activity of revumenib in combination with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alterations in KMT2A, NPM1, or NUP98 genes.
Conditions
- Acute Myeloid Leukemias
Interventions
RevumenibDrug
Participants will receive revumenib orally during Induction, Consolidation, and Maintenance until meeting criteria for discontinuation.
Chemotherapy RegimenDrug
Induction: Participants will receive an intravenous (IV), 2-drug combination of cytarabine and either daunorubicin or idarubicin.
HiDACDrug
Consolidation: Participants will receive HiDAC IV.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose Escalation: Number of Participants with Dose-limiting ToxicitiesTime frame: Up to Day 42
- Number of Participants with Treatment-emergent Adverse Events (TEAEs)Time frame: Day 1 through 30 days after final dose (up to approximately 3 years)
Locations
48 sites in 6 countries. Site status is shown where the registry gives one.
City of Hope
Goodyear, Arizona
UCLA Medical Hematology
Burbank, California
City of Hope Medical Center
Duarte, California
AdventHealth Blood & Marrow Transplant Center
Orlando, Florida
Tampa General Hospital
Tampa, Florida
Emory Winship Cancer Institute
Atlanta, Georgia
University of Illinois
Chicago, Illinois
University of Chicago
Chicago, Illinois
University of Louisville Health Brown Cancer Center
Louisville, Kentucky
Norton Cancer Institute, St. Matthews Campus
Louisville, Kentucky
Beth Israel Deaconess Medical Center
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Allina Health Cancer Institute
Minneapolis, Minnesota
Washington University School of Medicine
St Louis, Missouri
Institution name: Northwell Health-Brany
Lake Success, New York
Memorial Sloan Kettering Cancer Center
New York, New York
University of Rochester Medical Center
Rochester, New York
SUNY Upstate Medical University
Syracuse, New York
East Carolina University
Greenville, North Carolina
Atrium Health Wake Forest Baptist Medical Center
Winston-Salem, North Carolina
Cleveland Clinic Foundation
Cleveland, Ohio
Oregon Health and Science University- Center for Hematologic Malignancies
Portland, Oregon
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania
MUSC Hollings Cancer Center (HCC)
Charleston, South Carolina
Baylor University Medical Center
Dallas, Texas
The University of Texas, MD Anderson Cancer Center
Houston, Texas
LDS Hospital - Intermountain Healthcare
Salt Lake City, Utah
West Virginia University
Morgantown, West Virginia
Royal Adelaide Hospital
Adelaide, Australia
The Alfred Hospital, Victoria
Melbourne, Australia
Sir Charles Gairdner Hospital
Nedlands, Australia
Northern Hospital, Victoria
Epping, Victoria, Australia
Royal Perth Hospital
Perth, Western Australia, Australia
University of Alberta Hospital
Edmonton, Alberta, Canada
Gordon and Leslie Diamond Health Care Center
Vancouver, British Columbia, Canada
The Sir Mortimer B. Davis Jewish General Hospital
Montreal, Quebec, Canada
University Medical Center Utrecht
Utrecht, Netherlands
Hospital Clinic de Barcelona
Barcelona, Spain
Hospital San Pedro de Alcantara
Cáceres, Spain
Hospital Universitario Virgen de Las Nieves
Granada, Spain
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.